Ignite Creation Date:
2024-07-17 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06481969
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-25
Brief Title:
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
Sponsor:
Rui Yang
Organization:
Peking University Third Hospital
Study Overview
Official Title:
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
aSVF-POI
Brief Summary:
A single-center prospective randomised controlled clinical trial 11 treatment ratio designed to investigate the efficacy and safety of autologous SVF in improving the pregnancy outcome of infertile patients with POI
Detailed Description:
A single-center large-scale prospective randomized controlled clinical trial will enroll 260 patients diagnosed with POI based on the inclusion and exclusion criteria from Peking University Third Hospital Eligible participants will be randomized to two groups at a ratio of 11- SVF protocol and conventional protocolThe participation in this study will be approximately 2 years with a total of 6 visits and 3 follow-up phone calls
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None